$ Niks Prof (NPL.SI)
- Previous Close
0.1930 - Open
0.1950 - Bid 0.1790 x --
- Ask 0.1920 x --
- Day's Range
0.1790 - 0.1950 - 52 Week Range
0.1150 - 0.2000 - Volume
51,000 - Avg. Volume
14,245 - Market Cap (intraday)
25.09M - Beta (5Y Monthly) --
- PE Ratio (TTM)
9.65 - EPS (TTM)
0.0200 - Earnings Date --
- Forward Dividend & Yield 0.01 (5.18%)
- Ex-Dividend Date May 2, 2025
- 1y Target Est
--
Niks Professional Ltd., together with its subsidiaries, engages in the provision of family practice dermatology and aesthetic medical services in Singapore. It operates through three segments: Clinics, Retail, and Headquarters. The Clinics segment offers family practice dermatology services that include treatments with medicine, skincare products, and medical procedures for acne and acne scars, eczema, and pigmentation; and non-invasive and minimally invasive aesthetic medical services, such as intense pulsed light treatment, lasers for various treatments, and injectables. Its Retail segment provides NIKS skincare products, therapeutic facial, eye treatment, acne and comedone treatment, and microdermabrasion services; paramedical camouflage products and services; and treatments for hair thinning. The Headquarters segment engages in the online sale and distribution of NIKS skincare products to medical clinics and beauty salons in Singapore and China. The company offers its products and services under the NIKS brand. Niks Professional Ltd. was incorporated in 1998 and is headquartered in Singapore.
www.nikspro.com62
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NPL.SI
View MorePerformance Overview: NPL.SI
Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NPL.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NPL.SI
View MoreValuation Measures
Market Cap
25.09M
Enterprise Value
17.48M
Trailing P/E
12.06
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.24
Price/Book (mrq)
1.24
Enterprise Value/Revenue
1.56
Enterprise Value/EBITDA
4.88
Financial Highlights
Profitability and Income Statement
Profit Margin
18.24%
Return on Assets (ttm)
6.73%
Return on Equity (ttm)
10.51%
Revenue (ttm)
11.4M
Net Income Avi to Common (ttm)
2.08M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
9.25M
Total Debt/Equity (mrq)
7.77%
Levered Free Cash Flow (ttm)
1.64M